Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

“TY1 is the first exomer – a new class of drugs that address tissue damage in unexpected ways.” TY1 has the structure of existing RNA drugs, and works like its natural version – amplifying the ...

Microchips implanted into the back of the eyes of legally blind patients have helped some of them read again, according to a new study published Monday. Out of the 32 patients with geographic atrophy ...

Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...

Objectives: Mesothelin (MSLN) is a cell-surface glycoprotein overexpressed in the majority of pancreatic ductal adenocarcinoma (PDAC) cases and represents a promising immunotherapeutic target. Despite ...

Pimple patches seem to be soaring in popularity—and a newly invented type that makes zits disappear without pain or irrtitation in mere days could soon be all the rage. Researchers have created a ...

Fast, high-throughput quantification of multiplex immunofluorescence or immunohistochemistry staining in clinical specimens (tissue microarrays, whole tissue sections) by molecular ...

Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...